Browsing Tag

Beam Therapeutics

Beam Therapeutics Announces Upcoming Preclinical Data Presentations at the American…

Eli Pacheco Nov 4, 2021 0

Preclinical Data Demonstrates that BEAM-102 Makassar Base Editing Converts Sickle Hemoglobin to Functional Hemoglobin for Potential Treatment of Sickle Cell Disease New In Vivo Data…

Health

Beam Therapeutics to Present Preclinical Data Highlighting Potential of CAR T…

Eli Pacheco Oct 2, 2021 0

CAMBRIDGE, Mass., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today…

Newer Posts